In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice

M El Refaey, L Xu, Y Gao, BD Canan… - Circulation …, 2017 - Am Heart Assoc
Rationale: Duchenne muscular dystrophy is a severe inherited form of muscular dystrophy
caused by mutations in the reading frame of the dystrophin gene disrupting its protein …

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

CE Nelson, CH Hakim, DG Ousterout, PI Thakore… - Science, 2016 - science.org
Duchenne muscular dystrophy (DMD) is a devastating disease affecting about 1 out of 5000
male births and caused by mutations in the dystrophin gene. Genome editing has the …

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy

L Amoasii, C Long, H Li, AA Mireault… - Science translational …, 2017 - science.org
Duchenne muscular dystrophy (DMD) is a severe, progressive muscle disease caused by
mutations in the dystrophin gene. The majority of DMD mutations are deletions that …

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells

YL Min, H Li, C Rodriguez-Caycedo, AA Mireault… - Science …, 2019 - science.org
Mutations in the dystrophin gene cause Duchenne muscular dystrophy (DMD), which is
characterized by lethal degeneration of cardiac and skeletal muscles. Mutations that delete …

[HTML][HTML] Life-long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice

L Xu, YS Lau, Y Gao, H Li, R Han - Molecular Therapy, 2019 - cell.com
Previous studies from others and us have demonstrated that CRISPR genome editing could
offer a promising therapeutic strategy to restore dystrophin expression and function in the …

Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo

J Li, K Wang, Y Zhang, T Qi, J Yuan, L Zhang, H Qiu… - Circulation, 2021 - Am Heart Assoc
Background: Loss of dystrophin protein causes Duchenne muscular dystrophy (DMD),
characterized by progressive degeneration of cardiac and skeletal muscles, and mortality in …

[HTML][HTML] Correction of three prominent mutations in mouse and human models of Duchenne muscular dystrophy by single-cut genome editing

YL Min, F Chemello, H Li, C Rodriguez-Caycedo… - Molecular Therapy, 2020 - cell.com
Duchenne muscular dystrophy (DMD), one of the most common neuromuscular disorders of
children, is caused by the absence of dystrophin protein in striated muscle. Deletions of …

[HTML][HTML] Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy

A Pickar-Oliver, V Gough, JD Bohning, S Liu… - Molecular Therapy, 2021 - cell.com
Targeted gene-editing strategies have emerged as promising therapeutic approaches for
the permanent treatment of inherited genetic diseases. However, precise gene correction …

Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy

JN Robinson-Hamm, CA Gersbach - Human genetics, 2016 - Springer
Duchenne muscular dystrophy is one of the most common inherited genetic diseases and is
caused by mutations to the DMD gene that encodes the dystrophin protein. Recent …

[HTML][HTML] Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice

DR Karri, Y Zhang, F Chemello, YL Min, J Huang… - … Therapy-Nucleic Acids, 2022 - cell.com
Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by mutations in the
dystrophin gene. CRISPR/Cas9 genome editing has been used to correct DMD mutations in …